Phase II Study Comparing Conversion Rate to Surgery With Hepatic Arterial Infusion Chemotherapy to Systemic Chemotherapy in Patients With Non Resectable Liver-only Colorectal Metastases
PHASE2
Approximately 40% of colorectal cancer patients will develop colorectal liv...
Status
Unknown
Location
Severance Hospital, Yonsei University Health System
FOLFIRI in Combination With Cetuximab in the First-line Treatment of Metastatic Colorectal Cancer Including a Regular Dermal Prophylaxis to Prevent Acneiforme Follicular Exanthema
PHASE4
The purpose of this interventional study is to assess the progression free ...
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1,Chemotherapy and Target Therapy for Metastatic Colorectal Cancer
PHASE2
To improve the survival in patients with microsatellite stable metastatic c...